Certain confidential information contained in this document, marked by [***], has been omitted because Roivant Sciences Ltd. (the “Company”) has determined that the information (i) is not material and (ii) would likely cause competitive harm to the...Employment Agreement • July 29th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2022 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of May 19, 2020, by and between Mayukh Sukhatme, MD (the “Executive”) and Roivant Sciences, Inc. (the “Company”). This Agreement hereby amends and restates, effective as of May 19, 2020 (the “Effective Date”), the Executive’s prior employment agreement with the Company, dated April 28, 2015 (the “Prior Agreement”), and otherwise supersedes any and all prior and contemporaneous oral or written employment agreements or arrangements between the Executive and the Company or any predecessor thereof.